NCT07617805
- Conditions
- Biomarker-positive EGFR/HER2- Expressing HNSCC, Carcinoma, Carcinoma, Squamous Cell, +11 more
- Locations
-
- Peking University Shenzhen Hospital Shenzhen, Guangdong, China
Clinical trial condition
Explore clinical trials studying Carcinoma, Squamous Cell. Study availability and eligibility vary by location and protocol.
NCT07617805
NCT06980038
NCT07392580
NCT05039801
NCT06485778
NCT07452601
NCT06657222
NCT06648096
NCT06256588
NCT06953089